Suzanne Louise Bruhn
CIK 1517790 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.13M
Companies
11
Total Filings
60
Lifetime Open-Market Net
-$904.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DFTX | Director | 24,289 | $44.39 | $1.08M | $0 | 1 | 2026-06-15 |
| TVTX | Director | 32,750 | $62.76 | $2.06M | $0 | 6 | 2026-05-21 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | Director | 0 | $8.05 | $0 | $0 | 9 | 2025-08-05 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 19,623 | $15.00 | $294.3K | $0 | 4 | 2025-06-16 |
| PLRX | Director | — | $1.05 | — | $0 | 5 | 2025-06-09 |
| AVTX | Director | — | $18.84 | — | $0 | 1 | 2021-10-04 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | — | $2.93 | — | $0 | 8 | 2021-07-02 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 4 | 2020-06-10 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 5,250 | — | — | $0 | 1 | 2020-04-09 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | Director | — | — | — | $0 | 2 | 2018-08-13 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 8,330 | — | — | -$904.6K | 19 | 2016-10-26 |
Recent Filings · Page 6 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-01-15 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$26.4K | EDGAR |
| 2013-12-18 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$21.2K | EDGAR |
| 2013-11-15 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$20.7K | EDGAR |
| 2013-10-16 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$22.3K | EDGAR |
| 2013-10-09 | Raptor Pharmaceutical Corp (RPTP) Delisted | Exer (M) | +2,760 | $15.2K | EDGAR |
| 2013-09-17 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$29.6K | EDGAR |
| 2012-09-27 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-09-28 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-09-26 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-04-13 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 51–60 of 60
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.